About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
The Infection and Immunity in pediatric patients research group is a multidisciplinary pediatric research group made up of health professionals involved in translational research in the field of pediatric infectious diseases and immunodeficiencies, two related fields in terms of pathophysiology and clinical implications. It is a consolidated research group recognized by the AGAUR and is the only one with the accreditation of the Jeffrey Modell Foundation in research in the field of primary immunodeficiencies throughout the state.
The group was officially created in 2010, belongs to the area of Infectious Diseases and participates in the transversal programs of Advanced Translational Immunology and Rare Diseases and actively participates in national and international competitive projects, carries out multiple academic and industry-linked clinical trials and has increased the number and quality in recent years. In addition, it has its own laboratory specially dedicated to advanced immune studies.
PMID: 35255492 Journal: NATURE Year: 2022 Reference: Nature. 2022 Jul;607(7917):97-103. doi: 10.1038/s41586-022-04576-6. Epub 2022 Mar 7. Impact factor: 49.962 Publication type: Paper in international publication Authors: Tsinaslanidis, George; Birkinshaw, Isobel; Carter, Joseph; Howard, Kate; Ingham, Joanne; Joy, Rosie; Pearson, Harriet; Roche, Samantha; Scott, Zoe; Bancroft, Hollie et al. DOI: 10.1038/s41586-022-04576-6
PMID: 35752569 Journal: ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA Year: 2022 Reference: Enferm Infecc Microbiol Clin (Engl Ed). 2022 Jun 22. pii: S2529-993X(22)00132-0. doi: 10.1016/j.eimce.2022.06.002. Impact factor: 1.731 Publication type: Paper in international publication Authors: Ruiz-Botia, Irene; Riera-Bosch, M Teresa; Rodriguez-Losada, Olalla; Soler-Palacin, Pere; Melendo, Susana; Moraga-Llop, Fernando; Balcells-Ramirez, Joan; Otero-Romero, Susana; Armadans-Gil, Lluis et al. DOI: 10.1016/j.eimce.2022.06.002
PMID: 35754093 Journal: PEDIATRIC PULMONOLOGY Year: 2022 Reference: Pediatr Pulmonol. 2022 Jun 26. doi: 10.1002/ppul.26042. Impact factor: 3.039 Publication type: Paper in international publication Authors: Mesa, Juan Miguel; Dominguez-Rodriguez, Sara; Moraleda, Cinta; Tagarro, Alfredo; Rodriguez, Maria Jose; Galan, Juan Carlos; Barrios, Ana; Del Valle-Perez, Rut; Ballesteros, Alvaro; Calvo, Cristina et al. DOI: 10.1002/ppul.26042
PMID: 35766460 Journal: CLINICAL PEDIATRICS Year: 2022 Reference: Clin Pediatr (Phila). 2022 Jun 29:99228221106429. doi: 10.1177/00099228221106429. Impact factor: 1.168 Publication type: Paper in international publication Authors: Erika, Arno; Alfons, Macaya; Ignacio, Delgado-Alvarez; Ana, Felipe-Rucian; Jorgina, Vila; Duna, Casadesus-Cabral et al. DOI: 10.1177/00099228221106429
PMID: 34575764 Journal: Journal of Fungi Year: 2021 Reference: J Fungi (Basel). 2021 Sep 5;7(9). pii: jof7090726. doi: 10.3390/jof7090726. Impact factor: 5.816 Publication type: Letter or abstract Authors: Velasco-Nuno, Monica, Mendoza-Palomar, Natalia, Melendo-Perez, Susana, Balcells, Joan, Izquierdo-Blasco, Jaume, Martin-Gomez, Maria Teresa, Soler-Palacin, Pere, Riviere, Jacques G et al. DOI: 10.3390/jof7090726
PMID: 34413140 Journal: Science Immunology Year: 2021 Reference: Sci Immunol. 2021 Aug 19;6(62). pii: 6/62/eabl4348. doi: 10.1126/sciimmunol.abl4348. Impact factor: 17.727 Publication type: Paper in international publication Authors: Morelle, Guillaume, Asano, Takaki, Boisson, Bertrand, Onodi, Fanny, Shahrooei, Mohammad, Darazam, Ilad Alavi, Olyaei, Nasrin Alipour, Mansouri, Davood, Hatipoglu, Nevin, Palabiyik, Figen et al. DOI: 10.1126/sciimmunol.abl4348
PMID: 34413139 Journal: Science Immunology Year: 2021 Reference: Sci Immunol. 2021 Aug 19;6(62). pii: 6/62/eabl4340. doi: 10.1126/sciimmunol.abl4340. Impact factor: 17.727 Publication type: Paper in international publication Authors: Bastard, Paul, Gervais, Adrian, Le Voyer, Tom, Rosain, Jeremie, Philippot, Quentin, Manry, Jeremy, Michailidis, Eleftherios, Hoffmann, Hans-Heinrich, Eto, Shohei, Garcia-Prat, Marina et al. DOI: 10.1126/sciimmunol.abl4340
PMID: 34294672 Journal: International journal of neonatal screening Year: 2021 Reference: Int J Neonatal Screen. 2021 Jul 20;7(3). pii: ijns7030046. doi: 10.3390/ijns7030046. Impact factor: 0 Publication type: Paper in international publication Authors: Argudo-Ramirez, Ana, Martin-Nalda, Andrea, Gonzalez de Aledo-Castillo, Jose Manuel, Lopez-Galera, Rosa, Marin-Soria, Jose Luis, Pajares-Garcia, Sonia, Martinez-Gallo, Monica, Garcia-Prat, Marina, Colobran, Roger, Riviere, Jacques G et al. DOI: 10.3390/ijns7030046
The study seeks to better understand blood disorders in children and young people, analyzing the role of immunological alterations to improve diagnosis and treatment.
Members of the RBDCOV project, which involves VHIR, gathered at the Palau Macaya to review progress and achievements made during the final phase of the project.
During the meeting, the role of the Vall d'Hebron Paediatric Research Hub in promoting research on children and adolescents was highlighted.
